Kongressthemen The annual Macrophage-directed Therapies Summit returns as the leading industry focused summit dedicated to delivering clinical proof of concept through the effective translation of macrophage-directed therapies whilst ensuring safety, control and effective combination strategies.
Kongressgebühr Drug Developers (Earlybird rates, focus day and workshops available): USD 2099.00,
Academic (Earlybird rates and workshops available): USD 1899.00,
Service Providers (Earlybird rates and workshops available): USD 2499.00
Veranstalter Kontakt 83 Great Titchfield Street W1W 6RH London Großbritannien